# A new lead against resistant bacteria.

Scientists identified abaucin, a compound active against Acinetobacter baumannii, with help from deep learning.

Canonical: https://brightaifuture.com/discoveries/abaucin
Format: story
Source publication: 2023-05-25
Bright publication: 2026-09-05
Substantive update: None recorded
Evidence and review: Experimental; confidence: unassessed; source-checked; legacy source check. Legacy source check; no named human reviewer is recorded in this projection.

## The human problem

Antibiotic resistance narrows the options for treating infections.

## The prior constraint

Screening compounds experimentally is resource intensive.

## AI’s actual role

A model prioritized compounds for laboratory testing.

## The documented result

Abaucin showed activity in experiments, including a mouse wound infection model.

## Why it may matter

A possible starting point for developing a narrow-spectrum antibiotic.

## Limitations

Preclinical evidence. Human safety and efficacy are not established.

## Unresolved questions

Investigate mechanism, optimize the compound, and assess safety before clinical translation.

## Provenance and history

{
  "dates": {
    "eventDate": null,
    "publicationDate": "2023-05-25",
    "captureDate": null,
    "lastReviewedDate": "2026-09-05"
  },
  "provenance": {
    "origin": "legacy-projection",
    "externalId": "abaucin"
  },
  "revisions": [],
  "corrections": []
}

## Original sources

- [Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii · Nature Chemical Biology](https://www.nature.com/articles/s41589-023-01349-8)

## Continue exploring

- [Concise evidence record](https://brightaifuture.com/discoveries/abaucin)